Where to buy Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) and how much it costs

Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) is a fixed-dose combination drug, branded as Phesgo, for the treatment of adult patients with HER2-positive breast cancer that has spread to other parts of the body, and for the treatment of adult patients with HER2-positive early-stage breast cancer. It contains pertuzumab, trastuzumab, and hyaluronidasezzxf. Phesgo is injected under the skin through a subcutaneous injection in the thigh. In the EU, Phesgo contains the active ingredients pertuzumab and trastuzumab as well as hyaluronidase alfa.

HER2-positive breast cancers, which account for about one in five breast cancers, contain too much of a protein called human epidermal growth factor receptor 2 (HER2), which promotes the growth of cancer cells. Pertuzumab and trastuzumab bind to sites on HER2 and disrupt the signal to stop cancer cells from growing. The most common side effects include hair loss, nausea, diarrhea, anemia (low number of red blood cells), and asthenia (lack of energy), which can worsen chemotherapy-induced neutropenia (low levels of white blood cells). It may cause harm to a developing fetus or newborn baby.

The original Phesgo drug is not on the market in China, so it cannot be included in medical insurance. Domestic patients cannot yet purchase this drug. Since Phesgo's original drug has been on the market overseas for a short time, there is less price and other related information. For specific prices and drug information, please consult Yaode's medical consultant.